SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Raytheon Co – ‘10-K’ for 12/31/17 – ‘R23’

On:  Wednesday, 2/14/18, at 10:22am ET   ·   For:  12/31/17   ·   Accession #:  1047122-18-22   ·   File #:  1-13699

Previous ‘10-K’:  ‘10-K’ on 2/15/17 for 12/31/16   ·   Next:  ‘10-K’ on 2/13/19 for 12/31/18   ·   Latest:  ‘10-K/A’ on 4/1/20 for 12/31/19

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/14/18  Raytheon Co                       10-K       12/31/17  139:24M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.09M 
 2: EX-10.36    Summary of Executive Perquisites                    HTML     40K 
 4: EX-21       Subsidiaries of Raytheon Company                    HTML     40K 
 5: EX-23       Consent of Independent Registered Public            HTML     41K 
                Accounting Firm                                                  
 3: EX-12       Statement Regarding Computation of Ratio of         HTML     60K 
                Earnings to Fixed Charges                                        
 6: EX-31.1     Certification of Chairman and Chief Executive       HTML     47K 
                Officer, Section 302                                             
 7: EX-31.2     Certification of Vice President and Chief           HTML     47K 
                Financial Officer, Section 302                                   
 8: EX-32.1     Certification of Chairman and Chief Executive       HTML     41K 
                Officer, Section 906                                             
 9: EX-32.2     Certification of Vice President and Chief           HTML     42K 
                Financial Officer, Section 906                                   
16: R1          Document and Entity Information Document            HTML     69K 
17: R2          Consolidated Balance Sheets                         HTML    126K 
18: R3          Consolidated Balance Sheets Consolidated Balance    HTML     45K 
                Sheets (Parenthetical)                                           
19: R4          Consolidated Statements of Operations               HTML    129K 
20: R5          Consolidated Statements of Comprehensive Income     HTML     91K 
21: R6          Consolidated Statements of Equity                   HTML     87K 
22: R7          Consolidated Statements of Cash Flows               HTML    166K 
23: R8          Summary of Significant Accounting Policies          HTML    278K 
24: R9          Earnings Per Share (Eps)                            HTML     86K 
25: R10         eBorders Settlement                                 HTML     42K 
26: R11         Acquisitions and Goodwill                           HTML    109K 
27: R12         Thales-Raytheon Systems Co. Ltd. (TRS) Joint        HTML     44K 
                Venture                                                          
28: R13         Receivables, Net                                    HTML     53K 
29: R14         Contract Assets and Contract Liabilities            HTML     82K 
30: R15         Property, Plant and Equipment, Net                  HTML     54K 
31: R16         Other Assets, Net                                   HTML     58K 
32: R17         Commercial Paper and Long-term Debt                 HTML     88K 
33: R18         Commitments and Contingencies                       HTML     83K 
34: R19         Forcepoint Joint Venture                            HTML     59K 
35: R20         Stockholders' Equity                                HTML     76K 
36: R21         Stock-based Compensation Plans                      HTML    152K 
37: R22         Pension and Other Employee Benefits                 HTML    508K 
38: R23         Income Taxes                                        HTML    141K 
39: R24         Business Segment Reporting                          HTML    890K 
40: R25         Quarterly Operating Results (Unaudited)             HTML    135K 
41: R26         Summary of Significant Accounting Policies          HTML    364K 
                (Policies)                                                       
42: R27         Summary of Significant Accounting Policies          HTML    190K 
                (Tables)                                                         
43: R28         Earnings Per Share (Eps) (Tables)                   HTML     87K 
44: R29         Acquisitions and Goodwill (Tables)                  HTML    104K 
45: R30         Receivables, Net (Tables)                           HTML     50K 
46: R31         Contract Assets and Contract Liabilities (Tables)   HTML     76K 
47: R32         Property, Plant and Equipment, Net (Tables)         HTML     53K 
48: R33         Other Assets, Net (Tables)                          HTML     54K 
49: R34         Commercial Paper and Long-term Debt (Tables)        HTML     85K 
50: R35         Commitments and Contingencies (Tables)              HTML     77K 
51: R36         Forcepoint Joint Venture (Tables)                   HTML     55K 
52: R37         Stockholders' Equity (Tables)                       HTML     70K 
53: R38         Stock-based Compensation Plans (Tables)             HTML    150K 
54: R39         Pension and Other Employee Benefits (Tables)        HTML    506K 
55: R40         Income Taxes (Tables)                               HTML    132K 
56: R41         Business Segment Reporting (Tables)                 HTML    895K 
57: R42         Quarterly Operating Results (Unaudited) (Tables)    HTML    135K 
58: R43         Summary of Significant Accounting Policies          HTML    207K 
                (Narrative) (Details)                                            
59: R44         Summary of Significant Accounting Policies (Net     HTML     58K 
                EAC adjustments) (Details)                                       
60: R45         Summary of Significant Accounting Policies          HTML     49K 
                (Inventories) (Details)                                          
61: R46         Summary of Significant Accounting Policies          HTML     49K 
                (Property, Plant and Equipment, Net) (Details)                   
62: R47         Summary of Significant Accounting Policies          HTML    111K 
                (Accumulated Other Comprehensive Income) (Details)               
63: R48         Summary of Significant Accounting Policies (New     HTML     57K 
                Accounting Pronouncement, Early Adoption of ASU                  
                2014-09) (Details)                                               
64: R49         Summary of Significant Accounting Policies (New     HTML     54K 
                Accounting Pronouncement, Early Adoption of ASU                  
                2016-18) (Details)                                               
65: R50         Earnings Per Share (Eps) (Narrative) (Details)      HTML     56K 
66: R51         Earnings Per Share (Eps) (EPS from Continuing       HTML     67K 
                Operations) (Details)                                            
67: R52         Earnings Per Share (Eps) (Income from               HTML     49K 
                Participating Securities) (Details)                              
68: R53         Earnings Per Share (Eps) (Weighted-average Shares   HTML     52K 
                Outstanding for Basic and Diluted EPS) (Details)                 
69: R54         eBorders Settlement (Narrative) (Details)           HTML     48K 
70: R55         Acquisitions and Goodwill (Narrative) (Details)     HTML     80K 
71: R56         Acquisitions and Goodwill (Purchase Price           HTML     68K 
                Allocation) (Details)                                            
72: R57         Acquisitions and Goodwill (Intangible Assets        HTML     55K 
                Acquired) (Details)                                              
73: R58         Acquisitions and Goodwill (Rollforward of Goodwill  HTML     76K 
                by Segments) (Details)                                           
74: R59         Thales-Raytheon Systems Co. Ltd. (TRS) Joint        HTML     57K 
                Venture Thales-Raytheon Systems Co. Ltd. (TRS)                   
                Joint Venture (Narrative) (Details)                              
75: R60         Receivables, Net (Schedule of Receivables, Net)     HTML     50K 
                (Details)                                                        
76: R61         Contract Assets and Contract Liabilities            HTML     55K 
                (Narrative) (Details)                                            
77: R62         Contract Assets and Contract Liabilities (Net       HTML     65K 
                Contract Assets (Liabilities)) (Details)                         
78: R63         Contract Assets and Contract Liabilities (Schedule  HTML     55K 
                of Contract Assets) (Details)                                    
79: R64         Property, Plant and Equipment, Net (Narrative)      HTML     42K 
                (Details)                                                        
80: R65         Property, Plant and Equipment, Net (Property,       HTML     56K 
                Plant and Equipment, Net) (Details)                              
81: R66         Other Assets, Net (Narrative) (Details)             HTML     69K 
82: R67         Other Assets, Net (Schedule of Other Assets, Net)   HTML     58K 
                (Details)                                                        
83: R68         Commercial Paper and Long-term Debt (Narrative)     HTML     85K 
                (Details)                                                        
84: R69         Commercial Paper and Long-term Debt (Schedule of    HTML     73K 
                Notes Payable and Long-term Debt) (Details)                      
85: R70         Commercial Paper and Long-term Debt (Fair value of  HTML     41K 
                long-term debt) (Details)                                        
86: R71         Commercial Paper and Long-term Debt (Adjustments    HTML     67K 
                and payments to the Principal Amounts of Long-term               
                Debt) (Details)                                                  
87: R72         Commitments and Contingencies (Narrative)           HTML     53K 
                (Details)                                                        
88: R73         Commitments and Contingencies (Schedule of Annual   HTML     56K 
                Rentals on a Net Lease Basis) (Details)                          
89: R74         Commitments and Contingencies (Remediation Cost     HTML     50K 
                Estimates) (Details)                                             
90: R75         Commitments and Contingencies (Schedule of          HTML     54K 
                Environmental Remediation Costs) (Details)                       
91: R76         Commitments and Contingencies (Stated Values        HTML     47K 
                Outstanding) (Details)                                           
92: R77         Forcepoint Joint Venture (Narrative) (Details)      HTML     54K 
93: R78         Forcepoint Joint Venture (Redeemable                HTML     56K 
                Noncontrolling Interest Rollforward) (Details)                   
94: R79         Stockholders' Equity (Narrative) (Details)          HTML     78K 
95: R80         Stockholders' Equity (Changes in Shares of Common   HTML     49K 
                Stock Outstanding) (Details)                                     
96: R81         Stockholders' Equity (Repurchases of Common Stock   HTML     52K 
                Under Share Repurchase Programs) (Details)                       
97: R82         Stock-based Compensation Plans (Narrative)          HTML    113K 
                (Details)                                                        
98: R83         Stock-based Compensation Plans (Schedule of         HTML     53K 
                Stock-based Compensation) (Details)                              
99: R84         Stock-based Compensation Plans (Schedule of         HTML     74K 
                Stock-based Compensation Arrangements by                         
                Share-based Payment Award - Restricted Stock and                 
                RSUs) (Details)                                                  
100: R85         Stock-based Compensation Plans (Assumptions used    HTML     51K  
                in Monte Carlo Model) (Details)                                  
101: R86         Stock-based Compensation Plans (Schedule of         HTML     82K  
                Stock-based Compensation Arrangements by                         
                Share-based Payment Award - LTPP) (Details)                      
102: R87         Stock-based Compensation Plans (Assumptions used    HTML     56K  
                in Black-Scholes Model) (Details)                                
103: R88         Pension and Other Employee Benefits (Narrative)     HTML    146K  
                (Details)                                                        
104: R89         Pension and Other Employee Benefits (Fair value of  HTML     46K  
                plan assets) (Details)                                           
105: R90         Pension and Other Employee Benefits (Marketable     HTML     43K  
                securities held in trust) (Details)                              
106: R91         Pension and Other Employee Benefits (Pension        HTML     49K  
                Contributions) (Details)                                         
107: R92         Pension and Other Employee Benefits (Pension        HTML     59K  
                Benefits Expected to be Paid from Plans or                       
                Companies Assets) (Details)                                      
108: R93         Pension and Other Employee Benefits (Schedule of    HTML     62K  
                Components of Net Periodic Benefit Expense                       
                (Income) Pension) (Details)                                      
109: R94         Pension and Other Employee Benefits (Schedule of    HTML     62K  
                Components of Net Periodic Benefit Expense                       
                (Income) PRB Benefits) (Details)                                 
110: R95         Pension and Other Employee Benefits (Schedule of    HTML     58K  
                Funded Status Amounts Recognized on our Balance                  
                Sheets) (Details)                                                
111: R96         Pension and Other Employee Benefits (Schedule of    HTML     58K  
                Reconciliation of Amounts on our Balance Sheets)                 
                (Details)                                                        
112: R97         Pension and Other Employee Benefits (Source of      HTML     79K  
                Change in Accumulated Other Comprehensive Loss)                  
                (Details)                                                        
113: R98         Pension and Other Employee Benefits (Adjustment to  HTML     51K  
                Accumulated Other Comprehensive Loss) (Details)                  
114: R99         Pension and Other Employee Benefits (PBO & ABO      HTML     49K  
                Schedule) (Details)                                              
115: R100        Pension and Other Employee Benefits (Schedule of    HTML     70K  
                Change in Projected Benefit Obligation) (Details)                
116: R101        Pension and Other Employee Benefits (Schedule of    HTML     65K  
                Change in Plan Assets) (Details)                                 
117: R102        Pension and Other Employee Benefits (Schedule of    HTML     65K  
                Weighted-Average Net Periodic Benefit Cost                       
                Assumptions) (Details)                                           
118: R103        Pension and Other Employee Benefits (Schedule of    HTML     62K  
                Weighted-Average Year-End Benefit Obligation                     
                Assumptions) (Details)                                           
119: R104        Pension and Other Employee Benefits (Long-term      HTML     46K  
                returns used in ROA assumptions) (Details)                       
120: R105        Pension and Other Employee Benefits (Schedule of    HTML     69K  
                Investment Allocation Ranges) (Details)                          
121: R106        Pension and Other Employee Benefits (Schedule of    HTML    145K  
                Fair Value Measurements of the Company's Pension                 
                Plan Assets By Asset Category And By Level)                      
                (Details)                                                        
122: R107        Pension and Other Employee Benefits (VEBA Trusts)   HTML     53K  
                (Details)                                                        
123: R108        Income Taxes (Narrative) (Details)                  HTML     84K  
124: R109        Income Taxes (Schedule of Provision for Federal     HTML     60K  
                and Foreign Income Taxes) (Details)                              
125: R110        Income Taxes (Schedule of Expenses for Income       HTML     74K  
                Taxes that Differ from the US Statutory Rate                     
                Reconciliation) (Details)                                        
126: R111        Income Taxes (Schedule of Domestic and Foreign      HTML     45K  
                Income from continuing operations before taxes)                  
                (Details)                                                        
127: R112        Income Taxes (Schedule of Income Taxes Paid, Net)   HTML     48K  
                (Details)                                                        
128: R113        Income Taxes (Schedule of Deferred Income Tax)      HTML     69K  
                (Details)                                                        
129: R114        Business Segment Reporting (Segment Operating       HTML    122K  
                Performance) (Details)                                           
130: R115        Business Segment Reporting (Components of FAS/CAS   HTML     48K  
                Adjustment) (Details)                                            
131: R116        Business Segment Reporting (Capital Expenditures)   HTML     57K  
                (Details)                                                        
132: R117        Business Segment Reporting (Depreciation and        HTML     61K  
                Amortization) (Details)                                          
133: R118        Business Segment Reporting (Components of Total     HTML     56K  
                Assets) (Details)                                                
134: R119        Business Segment Reporting (Schedule of Property    HTML     47K  
                Plant and Equipment by Geographic Area) (Details)                
135: R120        Business Segment Reporting (Disaggregation of       HTML    480K  
                Revenue) (Details)                                               
136: R121        Quarterly Operating Results (Unaudited) (Schedule   HTML     96K  
                of Quarterly Operating Results) (Details)                        
138: XML         IDEA XML File -- Filing Summary                      XML    277K  
137: EXCEL       IDEA Workbook of Financial Reports                  XLSX    190K  
10: EX-101.INS  XBRL Instance -- rtn-20171231                        XML   9.49M 
12: EX-101.CAL  XBRL Calculations -- rtn-20171231_cal                XML    416K 
13: EX-101.DEF  XBRL Definitions -- rtn-20171231_def                 XML   1.82M 
14: EX-101.LAB  XBRL Labels -- rtn-20171231_lab                      XML   2.88M 
15: EX-101.PRE  XBRL Presentations -- rtn-20171231_pre               XML   2.09M 
11: EX-101.SCH  XBRL Schema -- rtn-20171231                          XSD    292K 
139: ZIP         XBRL Zipped Folder -- 0001047122-18-000022-xbrl      Zip    574K  


‘R23’   —   Income Taxes


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.8.0.1
Income Taxes
12 Months Ended
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
The provision for federal and foreign income taxes consisted of the following: 
(In millions)
2017

 
2016

 
2015

Current income tax expense (benefit)
 
 
 
 
 
Federal
$
822

 
$
713

 
$
757

Foreign
40

 
38

 
36

State

 
(3
)
 
(4
)
Deferred income tax expense (benefit)
 
 
 
 
 
Federal
235

 
118

 
(89
)
Foreign
18

 
6

 
45

State
(1
)
 
1

 
2

Total
$
1,114

 
$
873

 
$
747


 
The expense for income taxes differed from the U.S. statutory rate due to the following: 
 
2017

 
2016

 
2015

Statutory tax rate
35.0
 %
 
35.0
 %
 
35.0
 %
Research and development tax credit
(1.5
)
 
(1.3
)
 
(1.2
)
Tax settlements and refund claims

 

 
(3.2
)
Domestic manufacturing deduction benefit
(2.5
)
 
(2.7
)
 
(3.1
)
Foreign income tax rate differential
0.2

 

 
(1.4
)
Equity compensation
(1.2
)
 
(1.6
)
 

TRS tax-free gain

 
(1.8
)
 

Remeasurement of deferred taxes
3.2

 

 

One-time transition tax on previously undistributed foreign earnings
2.3

 

 

Other, net
0.3

 
0.7

 
0.2

Effective tax rate
35.8
 %
 
28.3
 %
 
26.3
 %


On December 22, 2017, the President signed the 2017 Act which enacts a wide range of changes to the U.S. corporate income tax system. The 2017 Act reduces the U.S. corporate tax rate to 21% effective in 2018, eliminates the domestic manufacturing deduction benefit and introduces other tax base broadening measures, changes rules for expensing and capitalizing business expenditures, establishes a territorial tax system for foreign earnings as well as a minimum tax on certain foreign earnings, provides for a one-time transition tax on previously undistributed foreign earnings, and introduces new rules for the treatment of certain export sales.

Also on December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (SAB 118), which provides companies with additional guidance on how to account for the 2017 Act in its financial statements, allowing companies to use a measurement period. At December 31, 2017, we have not completed our accounting for the tax effects of enactment of the Act; however, as described below, we have made a reasonable estimate of the effects on our existing deferred tax balances and the one-time transition tax. For these items, we recognized provisional amounts totaling $171 million in accordance with SAB 118, which are included as a component of income tax expense from continuing operations. We expect to finalize these provisional estimates before the end of 2018 after completing our reviews and analysis, including reviews and analysis of any interpretations issued during this measurement period.

Deferred tax assets and liabilities—We provisionally remeasured certain deferred tax assets and liabilities, excluding those items that will be included on our 2017 tax return, based on the rates we expect to realize the deferred tax assets and liabilities at in the future, which is generally 21%. However, we are still analyzing certain aspects of the Act, such as the transition rules and the minimum tax on foreign earnings, and refining our calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts in the measurement period. The provisional amount recorded related to the remeasurement of our deferred tax balance was $100 million of tax expense.

With the adoption of a minimum tax on foreign earnings, the Company will be subject to tax on global intangible low-taxed income (GILTI) in future years. We are continuing to evaluate this provision and will not make a policy election on how to account for GILTI (as a period expense or as part of our rate on deferred taxes) until we have the necessary information available, including the interpretations of the new rules, to analyze the impacts and complete our analysis. We will make an election before the end of 2018. Because we have not made a policy election, no amounts for GILTI are included in our deferred taxes.

Foreign tax effects—The one-time transition tax is based on our total post-1986 earnings and profits (E&P) for which we have previously deferred U.S. income taxes. We recorded a provisional amount for our one-time transition tax liability, using an estimated applicable tax rate of 15.5%, resulting in an increase in income tax expense of $71 million after accounting for foreign tax credits. We have not yet completed our calculation of the total post-1986 foreign E&P for these foreign subsidiaries. Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets. This amount may change when we finalize the calculation of post-1986 foreign E&P previously deferred from U.S. federal taxation and finalize the amounts held in cash or other specified assets. We also expect additional clarifying and interpretative technical guidance to be issued related to the calculation of our one-time transition tax. No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax and any additional outside basis difference inherent in these entities as these amounts continue to be indefinitely reinvested in foreign operations.

Although we believe the significant impacts from the 2017 Act are those described above, we continue to review and evaluate the other provisions of the 2017 Act. This review could result in changes to the amounts we have provisionally recorded. We expect to complete this review and evaluation before the end of 2018.

In the second quarter of 2016, the Company recorded a tax benefit of approximately $55 million as a result of the tax-free gain from the sale of our equity method investment in TRS SAS as discussed in “Note 5: Thales-Raytheon Systems Co. Ltd. (TRS) Joint Venture.”

In December 2015, U.S. legislation was enacted to permanently reinstate the Research and Development tax credit (R&D tax credit) which had expired on December 31, 2014. In 2017, 2016 and 2015 we recorded a full year benefit of approximately $46 million, $41 million and $33 million related to the 2017, 2016 and 2015 R&D tax credits, respectively.

We are subject to income taxes in the U.S. and numerous foreign jurisdictions. We have participated in the IRS Compliance Assurance Process (CAP) program since 2011. All IRS examinations of our tax years prior to 2015 are closed. We continue to participate in the CAP program for the 2015, 2016 and 2017 tax years. We are also under audit by multiple state and foreign tax authorities. In December 2017, we received the IRS Revenue Agent’s Report for the 2015 tax year which proposed approximately $41 million in adjustments related to the Forcepoint transaction and a U.K. share redemption transaction. We disagree with the adjustments and will protest the proposed adjustments with the IRS Appeals division.

(In millions)
2017

 
2016

 
2015

Domestic income from continuing operations before taxes
$
3,027

 
$
2,964

 
$
2,523

Foreign income from continuing operations before taxes
86

 
121

 
318



At December 31, 2017, foreign earnings of approximately $825 million have been taxed due to the one-time transition tax on previously undistributed foreign earnings required by the 2017 Act. For any future foreign earnings, the Company will generally be free of additional U.S. tax consequences due to a dividends received deduction implemented as part of the move to a territorial tax system for foreign subsidiary earnings. No provision has been made for deferred taxes related to any remaining historical outside basis differences in our non-U.S. subsidiaries. The Company continues to assert indefinite reinvestment in these outside basis differences generated on or before December 31, 2017. Determination of the amount of unrecognized deferred tax liability on outside basis differences is not practicable because of the complexity of laws and regulations, the varying tax treatment of alternative repatriation scenarios, and the variation due to multiple potential assumptions relating to the timing of any future repatriation.

We made the following net tax payments during the years ended December 31:
(In millions)
2017

 
2016

 
2015

Federal
$
765

 
$
710

 
$
1,008

Foreign
77

 
47

 
43

State
36

 
22

 
30



We believe that our income tax reserves are adequate; however, amounts asserted by taxing authorities could be greater or less than amounts accrued and reflected in our consolidated balance sheets. Accordingly, we could record adjustments to the amounts for federal, foreign, and state tax-related liabilities in the future as we revise estimates or we settle or otherwise resolve the underlying matters. In the ordinary course of business, we may take new positions that could increase or decrease our unrecognized tax benefits in future periods. As of December 31, 2017 and 2016, our liabilities associated with unrecognized tax benefits are not material.

With the exception of Forcepoint, we generally defer our state income tax expense to the extent we can recover this expense through the pricing of our products and services to the U.S. government. We include this deferred amount in prepaid expenses and other current assets until allocated to our contracts, which generally occurs upon payment or when otherwise agreed as allocable with the U.S. government. Net state income tax expense allocated to our contracts was $32 million, $26 million and $28 million in 2017, 2016 and 2015, respectively. We include state income tax expense allocated to our contracts in administrative and selling expenses.

Deferred income taxes consisted of the following at December 31:
(In millions)
2017

 
2016

Noncurrent deferred tax assets (liabilities)
 
 
 
Accrued employee compensation and benefits
$
202

 
$
293

Other accrued expenses and reserves
86

 
126

Contract balances and inventories
(537
)
 
(887
)
Pension benefits
1,505

 
2,368

Other retiree benefits
67

 
109

Net operating loss and tax credit carryforwards
99

 
121

Depreciation and amortization
(858
)
 
(1,343
)
Partnership outside basis difference
(36
)
 
(90
)
Other
21

 
52

Valuation allowance
(17
)
 
(38
)
Deferred income taxes—noncurrent
$
532

 
$
711


 
As of December 31, 2017, we had U.S. federal and state net operating loss (NOL) carryforwards related to Forcepoint of approximately $120 million and $182 million, respectively, which expire at various dates through 2036. We believe it is more likely than not that the deferred tax asset will be realized to the extent of existing deferred tax liabilities.

We also had foreign NOL carryforwards of approximately $136 million, with the majority generated in the U.K. where NOLs may be carried forward indefinitely. We believe that we have sufficient taxable income to realize these deferred tax assets.

The tax benefit related to discontinued operations was $1 million in 2017 and 2016 and $14 million in 2015.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/14/18
For Period end:12/31/1711-K,  SD
12/22/174
12/31/1610-K,  11-K,  SD
12/31/1410-K,  11-K,  ARS,  SD
 List all Filings 
Top
Filing Submission 0001047122-18-000022   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 10:35:15.1am ET